Global reorganisation of cis-regulatory units upon lineage commitment of human embryonic stem cells

  1. Paula Freire-Pritchett
  2. Stefan Schoenfelder
  3. Csilla Várnai
  4. Steven W Wingett
  5. Jonathan Cairns
  6. Amanda J Collier
  7. Raquel García-Vílchez
  8. Mayra Furlan-Magaril
  9. Cameron S Osborne
  10. Peter J Fraser
  11. Peter J Rugg-Gunn  Is a corresponding author
  12. Mikhail Spivakov  Is a corresponding author
  1. The Babraham Institute, United Kingdom
  2. Universidad Nacional Autónoma de México, Mexico
  3. King's College London School of Medicine, United Kingdom

Abstract

Long-range cis-regulatory elements such as enhancers coordinate cell-specific transcriptional programmes by engaging in DNA looping interactions with target promoters. Deciphering the interplay between the promoter connectivity and activity of cis-regulatory elements during lineage commitment is crucial for understanding developmental transcriptional control. Here, we use Promoter Capture Hi-C to generate a high-resolution atlas of chromosomal interactions involving ~22,000 gene promoters in human pluripotent and lineage-committed cells, identifying putative target genes for known and predicted enhancer elements. We reveal extensive dynamics of cis-regulatory contacts upon lineage commitment, including the acquisition and loss of promoter interactions. This spatial rewiring occurs preferentially with predicted changes in the activity of cis-regulatory elements, and is associated with changes in target gene expression. Our results provide a global and integrated view of promoter interactome dynamics during lineage commitment of human pluripotent cells.

Data availability

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Paula Freire-Pritchett

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Stefan Schoenfelder

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Csilla Várnai

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Steven W Wingett

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Jonathan Cairns

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Amanda J Collier

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Raquel García-Vílchez

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Mayra Furlan-Magaril

    Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City, Mexico
    Competing interests
    The authors declare that no competing interests exist.
  9. Cameron S Osborne

    Department of Genetics and Molecular Medicine, King's College London School of Medicine, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Peter J Fraser

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Peter J Rugg-Gunn

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    For correspondence
    peter.rugg-gunn@babraham.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
  12. Mikhail Spivakov

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    For correspondence
    mikhail.spivakov@babraham.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0383-3943

Funding

Wellcome (WT093736)

  • Peter J Rugg-Gunn

Biotechnology and Biological Sciences Research Council (BB/J004480/1)

  • Paula Freire-Pritchett
  • Stefan Schoenfelder
  • Csilla Várnai
  • Steven W Wingett
  • Jonathan Cairns
  • Mayra Furlan-Magaril
  • Peter J Fraser
  • Mikhail Spivakov

Medical Research Council (MR/J003808/1)

  • Amanda J Collier

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Freire-Pritchett et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,325
    views
  • 1,464
    downloads
  • 133
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Paula Freire-Pritchett
  2. Stefan Schoenfelder
  3. Csilla Várnai
  4. Steven W Wingett
  5. Jonathan Cairns
  6. Amanda J Collier
  7. Raquel García-Vílchez
  8. Mayra Furlan-Magaril
  9. Cameron S Osborne
  10. Peter J Fraser
  11. Peter J Rugg-Gunn
  12. Mikhail Spivakov
(2017)
Global reorganisation of cis-regulatory units upon lineage commitment of human embryonic stem cells
eLife 6:e21926.
https://doi.org/10.7554/eLife.21926

Share this article

https://doi.org/10.7554/eLife.21926

Further reading

    1. Stem Cells and Regenerative Medicine
    Tino Stauber, Greta Moschini ... Jess G Snedeker
    Research Article

    Tendinopathies are debilitating diseases currently increasing in prevalence and associated costs. There is a need to deepen our understanding of the underlying cell signaling pathways to unlock effective treatments. In this work, we screen cell signaling pathways in human tendinopathies and find positively enriched IL-6/JAK/STAT signaling alongside signatures of cell populations typically activated by IL-6 in other tissues. In human tendinopathic tendons, we also confirm the strong presence and co-localization of IL-6, IL-6R, and CD90, an established marker of reparative fibroblasts. To dissect the underlying causalities, we combine IL-6 knock-out mice with an explant-based assembloid model of tendon damage to successfully connect IL-6 signaling to reparative fibroblast activation and recruitment. Vice versa, we show that these reparative fibroblasts promote the development of tendinopathy hallmarks in the damaged explant upon IL-6 activation. We conclude that IL-6 activates tendon fibroblast populations which then initiate and deteriorate tendinopathy hallmarks.

    1. Stem Cells and Regenerative Medicine
    Ryosuke Isotani, Masaki Igarashi ... Toshimasa Yamauchi
    Research Article

    Cigarette smoking is a well-known risk factor inducing the development and progression of various diseases. Nicotine (NIC) is the major constituent of cigarette smoke. However, knowledge of the mechanism underlying the NIC-regulated stem cell functions is limited. In this study, we demonstrate that NIC increases the abundance and proliferative activity of murine intestinal stem cells (ISCs) in vivo and ex vivo. Moreover, NIC induces Yes-associated protein (YAP) /Transcriptional coactivator with PDZ-binding motif (TAZ) and Notch signaling in ISCs via α7-nicotinic acetylcholine receptor (nAchR) and protein kinase C (PKC) activation; this effect was not detected in Paneth cells. The inhibition of Notch signaling by dibenzazepine (DBZ) nullified the effects of NIC on ISCs. NIC enhances in vivo tumor formation from ISCs after loss of the tumor suppressor gene Apc, DBZ inhibited NIC-induced tumor growth. Hence, this study identifies a NIC-triggered pathway regulating the stemness and tumorigenicity of ISCs and suggests the use of DBZ as a potential therapeutic strategy for treating intestinal tumors.